Menu
Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 16
A Dermocosmetic Significantly Reduces the Frequency and Intensity of Facial Skin Intolerability and Sensitivity in Subjects with Skin Intolerant to Skin Care Products and Sensitive Skin [Corrigendum]
Authors Kerob D, Czermanska A, Karamon EM, Moga A, Lecerf G, Nioré M, Le Dantec G , Le Floc'h C , Tan J
Received 20 October 2023
Accepted for publication 20 October 2023
Published 25 October 2023 Volume 2023:16 Pages 3053—3055
Kerob D, Czermanska A, Karamon EM, et al. Clin Cosmet Investig Dermatol. 2023;16:1787–1794.
The authors have advised Figure 5b on page 1792 is incorrect. Due to an error that occurred inadvertently at the time of figure assembly, figure part b was duplicated from part a. The correct Figure 5 is shown below.
 |
Figure 5 Biomarkers at Day 0 and Day 14. (a) Interleukin 1α. (b) Interleukin-1-receptor antagonist. (c) Prostaglandin E2. Differences from Day 0 were statistically significant (*p<0.0001) for all 3 biomarkers after 14 days of daily use. |
The authors apologize for this error and advise it does not affect the results of the paper.
© 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.